VOYGbusinesswire

Voyager Enables Microgravity-Enabled Drug Discovery

Summary

DENVER--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) announced a new contract with Space LiinTech to manifest a new payload to the International Space Station, advancing microgravity-enabled drug discovery. “The most important breakthroughs in space-enabled medicine will come from consistent, high-fidelity access to orbit,” said Matt Magaña, president, Space, Defense & National Security at Voyager. “Microgravity changes crystallization, growth dynamics and material properties at a fun

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on January 22, 2026 by businesswire